Literature DB >> 15893521

Agonist-induced up-regulation of human somatostatin receptor type 1 is regulated by beta-arrestin-1 and requires an essential serine residue in the receptor C-tail.

José L Ramírez1, Heather L Watt, Magalie Rocheville, Ujendra Kumar.   

Abstract

We have previously shown that the human somatostatin receptor type 1 (hSSTR1) does not undergo agonist-induced internalization, but is instead up-regulated at the membrane upon prolonged somatostatin (SST) exposure. The deletion of the carboxyterminal C-tail of the receptor completely abolishes up-regulation. To identify molecular signals that mediate hSSTR1 up-regulation, we created mutant receptors with progressive C-tail deletions. Up-regulation was found to be absent in mutants lacking residues Lys359-Ser360-Arg361. Moreover, point mutation of Ser360 to Ala completely abolished up-regulation. The coexpression of wild type hSSTR1 with V53D, a dominant negative mutant of beta-arrestin-1, completely blocked hSSTR1 up-regulation. Further analysis demonstrated that calcium-calmodulin (CaM) dependent kinases were essential for the SST-induced up-regulation response. Like wild type receptors, all mutants failed to internalize after agonist exposure and were able to inhibit forskolin-stimulated cAMP accumulation. Taking these data together, we suggest that SST-induced hSSTR1 up-regulation is critically dependent upon a specific Lys-Ser-Arg sequence in the C-tail of the receptor, with Ser360 being essential. Up-regulation also requires the participation of CaM protein kinases and interactions with beta-arrestins. In contrast, coupling to adenyl cyclase (AC) and internalization occur independently of molecular signals in the receptor's C-tail.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893521     DOI: 10.1016/j.bbamem.2005.02.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

Review 1.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

2.  GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation.

Authors:  Lars Wichmann Madsen; Jeffrey A Knauf; Carsten Gotfredsen; Andrew Pilling; Ingrid Sjögren; Søren Andersen; Lene Andersen; Anne Sietske de Boer; Katia Manova; Afsar Barlas; Sushil Vundavalli; Niels C Berg Nyborg; Lotte Bjerre Knudsen; Anne Marie Moelck; James A Fagin
Journal:  Endocrinology       Date:  2012-01-10       Impact factor: 4.736

3.  Glutamate differently modulates metabotropic glutamate receptors in neuronal and glial cells.

Authors:  Carlos Alberto Castillo; David Agustín León; Inmaculada Ballesteros-Yáñez; Inmaculada Iglesias; Mairena Martín; José Luis Albasanz
Journal:  Neurochem Res       Date:  2010-03-23       Impact factor: 3.996

4.  Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis.

Authors:  Roy Moncayo
Journal:  EJNMMI Res       Date:  2011-07-26       Impact factor: 3.138

5.  Colocalization of somatostatin receptors and epidermal growth factor receptors in breast cancer cells.

Authors:  Heather L Watt; Ujendra Kumar
Journal:  Cancer Cell Int       Date:  2006-03-06       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.